Indication
*NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. NeuroStar TMS Therapy is available by prescription only and delivered under the supervision of a psychiatrist. Click Here for Full Safety and Prescribing Information.

Important Safety Information
NeuroStar TMS Therapy should not be used (is contraindicated) in patients with implanted metallic devices or non-removable metallic objects in or around the head or for patients who have certain device implants such as deep brain stimulators, cochlear implants and vagus nerve stimulators.

NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment. Its effectiveness as a treatment for depression has also not been established in patients who have failed to receive benefit from two or more prior antidepressant medications at minimal effective dose and duration in the current episode.

In a multi-center, randomized controlled clinical trial, patients treated with active NeuroStar TMS Therapy experienced an average reduction in their depression symptoms of 22.1% compared to a 9% average reduction of depression symptoms in patients receiving inactive treatment.

The most common side effect associated with treatment is scalp pain or discomfort - generally mild to moderate and occurring less frequently after the first week of treatment. There is a rare risk of seizure associated with the use of TMS. You should talk with your physician to determine if NeuroStar TMS Therapy may be right for you.